A critical evaluation of the role of subcutaneous abatacept in the treatment of rheumatoid arthritis: patient considerations
Alvin F Wells,1,2 Nicole Jodat,1 Michael Schiff3 1Rheumatology and Immunotherapy Center, Franklin, WI, USA; 2Duke University Medical Center, Durham, NC, USA; 3University of Colorado, School of Medicine, Denver, CO, USA Abstract: There are now more therapeutic options for the treatment of rheumato...
Guardado en:
Autores principales: | Wells AF, Jodat N, Schiff M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d75d2e61e6324effb24702585f8df838 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis
por: Mathieu S, et al.
Publicado: (2013) -
Critical appraisal of efficacy and safety of abatacept in the treatment of refractory rheumatoid arthritis
por: Augustine JM, et al.
Publicado: (2012) -
Efficacy, safety, and tolerability of abatacept in the management of rheumatoid arthritis
por: Joseph R Lutt
Publicado: (2009) -
Abatacept in difficult-to-treat juvenile idiopathic arthritis
por: Jasmin B Kuemmerle-Deschner, et al.
Publicado: (2009) -
Factors correlated with the improvement of endothelial dysfunction during Abatacept therapy in patients with rheumatoid arthritis
por: Benucci M, et al.
Publicado: (2018)